US Patent 7279473 Pyrazolopyridazine derivatives
Patent 7279473 was granted and assigned to Smithkline Beecham Limited on October, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+278 characters)
Article
Patent abstract
Fused pyradazine derivatives which are usefule as CDK inhibitors are described herein. The described invention alos includes methods of making such fused pyradazine derivatives as wells as methods of using the same in the treatment of hyperproliferative diseases.
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07279473 Pyrazolopyridazine derivatives US Patent 7279473 Pyrazolopyridazine derivatives
Infobox
Patent Number
0727947300
Patent Number
727947300
Edits on 25 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072794730
Date of Patent
October 9, 2007
0Patent Application Number
104991790
Date Filed
December 11, 2002
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072794730
Date of Patent
October 9, 2007
0Patent Application Number
104991790
Date Filed
December 11, 2002
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07279473 Pyrazolopyridazine derivatives
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07279473
Date of patent
October 9, 2007
Patent application number
10499179
Date Filed
December 11, 2002
Patent primary examiner
Find more entities like US Patent 7279473 Pyrazolopyridazine derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.